The two companies reportedly could not agree on a price, leaving pharma’s first potential megadeal of 2026 on ice.

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

Our senior market strategist explains which ETFs offer exposure to high-powered biotech growth, without T. Rex-sized risk.

Depending who you ask, AI-powered coding is either giving software developers an unprecedented productivity boost or churning ...

A medical device company from Ireland, a biotech startup developing cancer therapeutics from Pennsylvania and a venture studio focused on women’s health from Massachusetts are among eight recipients ...

Showcase your company news with guaranteed exposure both in print and online Discover how AI and emerging technologies are reshaping business and the cybersecurity strategies needed to… Where Ambition ...

Investors in biotech companies approach their investments with the mindset of praying or scratching a lottery ticket, as the success rate of new drug development is extremely low and the costs are ...

PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...

When it comes to beauty formulations that are inclusive of people and planet, finding a middle ground is not always easy. Natural ingredients often rely on farming practices that often require a lot ...